Twitter | Search | |
Search Refresh
Ricardo Carvalho 24 Sep 17
Will you make it available on Webcast the "proffered paper sessions" of ? Only abstracts of these session R available so far
Reply Retweet Like
Elizabeth Plimack MD 4 Nov 17
Axel Bex: challanges/lessons from cytoreductive nephrectomy RCTs . ICYMI : deferred ?better than upfront CN 4 met
Reply Retweet Like
Elsevier Oncology 22 Sep 17
Cardiotoxicity under capecitabine treatment
Reply Retweet Like
ESMO - Eur. Oncology 11 Apr 18
What happens when meets !
Reply Retweet Like
Declan Murphy 30 Oct 17
Actually LuPSMA responses much more impressive - perhaps u missed prospective data incl dosimetry
Reply Retweet Like
Yale Urology May 10
"So we concluded that this is a viable treatment option for those patients with previous chemotherapy for urothelial carcinoma." Watch Dr. Dan Petrylak talk about the exciting results of the RANGE Trial at in Madrid.
Reply Retweet Like
Dr Snezana Bosnjak 25 Sep 17
Patients' ranking of the most troublesome CT side-effects has shifted: nausea and vomiting are no longer among top 5, by
Reply Retweet Like
ecancer May 1
Latest approvals include treating patients with BRAF mutations with a combination of dabrafenib and trametinib after surgery. For more on this combination, watch our interview with Dr Alex Hauschild about the trial at
Reply Retweet Like
Charles Ferté 28 Oct 17
Very proud Roger Sun gave a talk on our radiomics predictor of immune infiltration & had poster award !
Reply Retweet Like
Jo Taylor Jul 15
Yes showed this at & when I was one of the top influencers of the conferences - patients help massively to share information via their own networks to engage with others RT
Reply Retweet Like
EMJ Reviews May 14
Reply Retweet Like
Medscape Oncology 29 Sep 17
MIRO: Minimally invasive surgery for esophageal cancer
Reply Retweet Like
Novartis Cancer 21 Sep 17
US Only: Attention US health care providers! If you missed , you can register to view virtual sessions here:
Reply Retweet Like
ESMO - Eur. Oncology Oct 17
Getting excited about ? Take a look back at key moments from in Madrid - guaranteed to heighten expectations here in Munich!
Reply Retweet Like
AML Global Portal 20 Oct 17
Phase I study of flotetuzumab in and patients Read more here:
Reply Retweet Like
Oncology Tube 13 Oct 17
Reply Retweet Like
Andrew Schorr 30 Nov 17
can be a devastating dx, affecting quality of life. Chris Curtis of is someone who has come through it and is a leading mentor for so many. Hear his story,know you are not alone & that there is hope!
Reply Retweet Like
NatureRevClinOncol 26 Sep 17
Reply Retweet Like
medwireNews 4 Oct 17
In the last of our interviews, expert Rodrigo Dienstmann comments on the RANGE & CheckMate214 trials
Reply Retweet Like
Deborah W. Bruner 24 Sep 17
. has 6 presentations on Monday including a plenary! Check out latest in
Reply Retweet Like